BioSpace News Archive

Genetown

AGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Applied Genetic Technologies Corporation today announced it had exceeded the enrollment target in the Company’s SKYLINE trial of AGTC-501, a recombinant AAV vector-based gene therapy developed for the treatment of X-linked retinitis pigmentosa (XLRP).

January 11, 2022
·
7 min read
Genetown

Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External Collaborations

Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative disease, today provided an update on recent corporate developments.

January 11, 2022
·
7 min read
Business

iCAD Announces the Appointment of New Members to its Board of Directors

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, announced it has appointed Dana Brown and Timothy Norris Irish as new independent members of the Board of Directors, effective January 10, 2022.

January 11, 2022
·
5 min read
Business

ORYZON Announces New Senior VP of Clinical Development and Global Medical Affairs, Continuing its Expansion of US Corporate Activities

Oryzon Genomics, S.A. announced that Dr. Ana Limón has been appointed as Senior Vice President of Clinical Development and Global Medical Affairs.

January 11, 2022
·
5 min read
Business

Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021

Fluidigm Corporation announced preliminary revenue for the fourth quarter and full year ended December 31, 2021, exceeding the company’s guidance for those periods.

January 11, 2022
·
4 min read
Biotech Bay

Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today provided an update on its PLN-74809 program.

January 11, 2022
·
6 min read
Business

AUM Biosciences Identifies Asymchem as the CDMO Partner of Choice for their Novel TRK inhibitor

Asymchem, a leading global contract development and manufacturing service provider, and AUM Biosciences, a global clinical stage biotech company, focused on discovering, acquiring and developing next generation targeted oncology therapeutics, jointly announced a collaboration agreement.

January 11, 2022
·
3 min read
Business

Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs

Cardiff Oncology, Inc. today announced the appointments of Tod Smeal, Ph.D., as chief scientific officer (CSO) and Charles Monahan, RPh, as senior vice president, regulatory affairs.

January 11, 2022
·
8 min read
Pharm Country

Clario and XingImaging expand partnership to deliver PET imaging clinical trials in China

Clario and XingImaging have expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China.

January 11, 2022
·
2 min read
Genetown

Totus Medicines to Present at 2022 J.P. Morgan HealthCare Conference

Totus Medicines today announced that CEO and co-founder Neil Dhawan , Ph.D. will present at the 40th annual J.P. Morgan HealthCare Conference on Thursday, January 13 , at 8:00am ET .

January 11, 2022
·
1 min read